Antibody-mediated neutralization of human immunodeficiency virus type-1 (HIV-1) is thought to function by at least two distinct mechanisms: inhibition of virus-receptor binding, and interference with events after binding, such as virus-cell membrane fusion. Here we show, by the use of a novel virus-cell binding assay, that soluble CD4 and monoclonal antibodies to all confirmed glycoprotein (gp)120 neutralizing epitopes, including the CD4 binding site and the V2 and V3 loops, inhibit the adsorption of two T cell line-adapted HIV-1 viruses to CD4+ cells. A correlation between the inhibition of virus binding and virus neutralization was observed for soluble CD4 and all anti-gp120 antibodies, indicating that this is a major mechanism of HIV neu...
A murine monoclonal antibody (MAb F-91-55) raised against the complex of soluble CD4 and human immun...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
International audienceThe neutralizing activity of anti-HIV-1 antibodies is typically measured in as...
The envelope glycoproteins of HIV, gp120 and gp41, contain epitopes recognized by neutralizing antib...
The major target of the neutralizing antibody response to infection by the human immunodeficiency vi...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies whose binding to gp120 is enhanced by CD...
Neutralisation by antibody is, for a number of viruses, an in vitro correlate for protection in vivo...
Neutralizing antibodies often recognize regions of viral envelope glycoproteins that play a role in ...
We investigated the relative importance of binding site occupancy and epitope specificity in antibod...
Human immunodeficiency virus type 1 (HIV-1) infection can spread efficiently from infected to uninfe...
AbstractSpecific conformational changes in the envelope glycoprotein gp120 of the human immunodefici...
AbstractIn this study, progeny viruses of four HIV-1 molecular clones were tested for sensitivity to...
AbstractDifferent isolates of HIV-1 are known to vary in antibody binding and sensitivity to neutral...
We have used cells infected with the HIV-1 molecular clone HX10 to study the binding of monoclonal a...
A murine monoclonal antibody (MAb F-91-55) raised against the complex of soluble CD4 and human immun...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
International audienceThe neutralizing activity of anti-HIV-1 antibodies is typically measured in as...
The envelope glycoproteins of HIV, gp120 and gp41, contain epitopes recognized by neutralizing antib...
The major target of the neutralizing antibody response to infection by the human immunodeficiency vi...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies whose binding to gp120 is enhanced by CD...
Neutralisation by antibody is, for a number of viruses, an in vitro correlate for protection in vivo...
Neutralizing antibodies often recognize regions of viral envelope glycoproteins that play a role in ...
We investigated the relative importance of binding site occupancy and epitope specificity in antibod...
Human immunodeficiency virus type 1 (HIV-1) infection can spread efficiently from infected to uninfe...
AbstractSpecific conformational changes in the envelope glycoprotein gp120 of the human immunodefici...
AbstractIn this study, progeny viruses of four HIV-1 molecular clones were tested for sensitivity to...
AbstractDifferent isolates of HIV-1 are known to vary in antibody binding and sensitivity to neutral...
We have used cells infected with the HIV-1 molecular clone HX10 to study the binding of monoclonal a...
A murine monoclonal antibody (MAb F-91-55) raised against the complex of soluble CD4 and human immun...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
International audienceThe neutralizing activity of anti-HIV-1 antibodies is typically measured in as...